Wednesday, September 9, 2026
spot_img

KBC Group: Results of the capital increase of KBC Group NV for the employees and effects on the transparency obligations

The traditional annual capital increase reserved for the employees of KBC Group NV and some of its Belgian subsidiaries had, dd. 13 December 2024, the following effects on the share capital and the amount of shares/voting rights* of KBC Group NV.

– The share capital increased by 836 345.25 EUR to 1 461 854 095.51 EUR.
– The total number of shares increased by 238 275 to 417 544 151 shares. The total number of
   voting rights also increased by 238 275 to 417 544 151.

The most recent information on the capital and the number of shares of KBC Group NV can be consulted on www.kbc.com.

*  The voting rights of the treasury shares held by KBC Group NV and its subsidiaries – including the shares purchased as a result of the share buyback plan launched in August 2023 and terminated at the end of July 2024 – have been suspended.

Transparency legislation aims to create transparency in the shareholder structure of listed companies. To achieve this, investors in such companies are required – when certain thresholds are crossed – to inform the company concerned of their participation by means of notifications. For KBC Group NV, the statutory threshold for notifications is 3% of the total number of voting rights. Statutory thresholds of 5% and multiples thereof apply above this level. These notifications should be sent to our e-mail address: [email protected]

For more information, please contact:

Kurt De Baenst, General Manager, Investor Relations, KBC Group
E-mail:  [email protected]

Viviane Huybrecht, General Manager, Corporate Communication/Spokesperson, KBC Group
E-mail: [email protected]

* This press release contains information provided in compliance with European transparency legislation for listed companies. KBC Group NV is listed at NYSE Brussels.

KBC Group NV
Havenlaan 2 – 1080 Brussels
Viviane Huybrecht
Katleen Dewaele
General Manager, Corporate
Communication/
Spokesperson
Tel. + 32 2 429 85 45

Press Office
Tel. +32 2 429 29 15 Ilse De Muyer
Tel. +32 2 429 32 88 Pieter Kussé
Tel. +32 2 429 85 44 Sofie Spiessens
Tel. +32 2 429 29 49 Tomas Meyers
E-mail: [email protected]

KBC press releases are available at www.kbc.com or can be obtained by sending an e-mail to [email protected]

 

Follow us on www.twitter.com/kbc_group

Attachment

  • 20241216-capital-increase-en

Powered by SlickText.com

Hot this week

Form 8.3 – Picton Property Income Limited

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A...

Form 8.3 – NextEnergy Solar Fund Limited

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A...

Form 8.3 – LondonMetric Property Plc & Schroder Real Estate Investment Trust Limited

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A...

Decisions of the Richemont 2026 Annual General Meeting

9 SEPTEMBER 2026 DECISIONS OF THE RICHEMONT 2026...

MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management

Collaboration combines Rose Pharma investigational rapid-acting GLP-1 receptor agonist...

Topics

Form 8.3 – Picton Property Income Limited

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A...

Form 8.3 – NextEnergy Solar Fund Limited

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A...

Form 8.3 – LondonMetric Property Plc & Schroder Real Estate Investment Trust Limited

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A...

Decisions of the Richemont 2026 Annual General Meeting

9 SEPTEMBER 2026 DECISIONS OF THE RICHEMONT 2026...

Azimut Accelerates District-Scale Gold Exploration at Wabamisk

30 km by 2 km prospective corridor encompasses Rosa...
spot_img

Related Articles

Popular Categories

spot_img